Table 2.

Assessment of GVHD Tissue Damage in IUT and Postnatal BMT Recipients

GroupBM Dose (×106) Liver Lung ColonSpleen
IUT congenic  4.0  0.0 (0.0)  0.3 (0.3) 0.3 (0.3)  0.0 (0.0)  
IUT TCD  4.0  0.0 (0.0) 0.6 (0.2)  0.8 (0.2)  0.5 (0.2)* 
IUT NTCD  4.0 0.0 (0.0)  1.2 (0.4)  0.1 (0.1)  0.4 (0.2)  
SCID TCD  25.0  1.4 (0.7) 2.3 (0.2)* 1.1 (0.4) 1.0 (0.0)* 
SCID NTCD  25.0  2.4 (0.3)* 1.9 (0.5)* 1.0 (0.6)  1.8 (0.3)* 
TBI TCD  4.0  0.1 (0.1) 0.3 (0.3)  0.5 (0.2)  0.0 (0.0) 
GroupBM Dose (×106) Liver Lung ColonSpleen
IUT congenic  4.0  0.0 (0.0)  0.3 (0.3) 0.3 (0.3)  0.0 (0.0)  
IUT TCD  4.0  0.0 (0.0) 0.6 (0.2)  0.8 (0.2)  0.5 (0.2)* 
IUT NTCD  4.0 0.0 (0.0)  1.2 (0.4)  0.1 (0.1)  0.4 (0.2)  
SCID TCD  25.0  1.4 (0.7) 2.3 (0.2)* 1.1 (0.4) 1.0 (0.0)* 
SCID NTCD  25.0  2.4 (0.3)* 1.9 (0.5)* 1.0 (0.6)  1.8 (0.3)* 
TBI TCD  4.0  0.1 (0.1) 0.3 (0.3)  0.5 (0.2)  0.0 (0.0) 

Coded tissue samples from 4 high-level chimeras per group were analyzed using a semiquantitative GVH scoring system. Data are the mean values of the individual scores and in parentheses is shown one standard error of the mean.

*

P ≤ .05 versus IUT congenic recipients.

.05 < P < .1 versus IUT congenic recipients.

Close Modal

or Create an Account

Close Modal
Close Modal